AtaiBeckleyATAI -4.43%56 PS Ratio is 381.54 as of Jul. 06, 2026, which is 48% below its 10-year median of 740.00. GuruFocus rates ATAI with a GF Score™ of 56/100 and a GF Value™ of $7.16 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 929 Biotechnology companies, AtaiBeckley ranks worse than 92.68% on this metric.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. As of today, AtaiBeckley's share price is $4.96.
AtaiBeckley's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 was $0.01. Hence, AtaiBeckley's PS Ratio for today is 381.54.
Warning Sign:
AtaiBeckley Inc stock PS Ratio (=399.23) is close to 1-year high of 406.92.
The historical rank and industry rank for AtaiBeckley's PS Ratio or its related term are showing as below:
ATAI'
s PS Ratio Range Over the Past 10 Years
Min: 36.59 Med: 740 Max: 2450
Current: 381.55
During the past 7 years, AtaiBeckley's highest PS Ratio was 2450.00. The lowest was 36.59. And the median was 740.00.
ATAI's PS Ratio is ranked worse than 92.68% of 929
companies
in the Biotechnology industry
Industry Median: 9.91
vs ATAI: 381.55
During the past 12 months, the average Revenue per Share Growth Rate of AtaiBeckley was 18.20% per year.
During the past 3 years, the average Revenue per Share Growth Rate was 162.10% per year.
During the past 7 years, AtaiBeckley's highest 3-Year average Revenue per Share Growth Rate was 162.10% per year. The lowest was -76.10% per year. And the median was 43.00% per year.
Back to Basics: PS Ratio
AtaiBeckley (NAS:ATAI) PS Ratio Explanation
The PS Ratio is an excellent valuation indicator if you want to compare a stock with its historical valuation or with the stocks in the same industry. The PS Ratio works especially well when you want to compare the stock's current valuation with its historical valuation. The PS Ratio is a great valuation tool for evaluating cyclical businesses where the PE Ratio works poorly. It works the best when comparing the current valuation with the historical valuation because over time, a company's profit margin tends to revert to the mean.
When the PS Ratio is applied to the whole stock market, it can be used to evaluate the current market valuation and projected returns. In this case, the price is the total market cap of all stocks that are traded, and sales are the GDP of the country. This is how Warren Buffett estimates the broad market valuation and project future returns.
The PS Ratio does not tell you how cheap or expensive the stock is. It cannot be used to compare companies in different industries. It works better for companies within the same industry because these companies tend to have similar capital structures and profit margins. It works the best when comparing a company with itself in the past.
AtaiBeckley PS Ratio Related Terms
AtaiBeckley PS Ratio Historical Data
* Premium members only.
The historical data trend for AtaiBeckley's PS Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, AtaiBeckley's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AtaiBeckley PS Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, AtaiBeckley's PS Ratio distribution charts can be found below:
* The bar in red indicates where AtaiBeckley's PS Ratio falls into.
The PS Ratio, or Price-to-Sales ratio, or Price/Sales, is a financial ratio used to compare a company's market price to its Revenue per Share. It is a ratio widely used to value stocks and it was first used by Ken Fisher.
AtaiBeckley's Share Price of today is $4.96. AtaiBeckley's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.01.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
AtaiBeckley (ATAI) has a PS Ratio of 381.54 as of Jul. 06, 2026. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on AtaiBeckley and its competitors. This is 48% below median its historical median of 740.00. Over the past decade, AtaiBeckley's PS Ratio has ranged from 36.59 to 2,450.00. According to the industry distribution chart, AtaiBeckley ranks #861 out of 929 companies in the Biotechnology industry, placing it in the top 92.7%.
Is AtaiBeckley's PS Ratio too high?
AtaiBeckley's current PS Ratio of 381.54 is 48% below median its 10-year median of 740.00. Over the past 10 years, this metric has ranged from a low of 36.59 to a high of 2,450.00. The Biotechnology industry median PS Ratio is 9.91. AtaiBeckley's value of 381.54 is 3750.1% above this industry median. Based on the distribution chart, AtaiBeckley ranks #861 out of 929 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, AtaiBeckley has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does AtaiBeckley's PS Ratio compare to GHRS and NUVB?
According to the Biotechnology industry distribution chart, AtaiBeckley ranks #861 out of 929 companies for PS Ratio. This places AtaiBeckley in the lower half of its industry. The industry median PS Ratio is 9.91. AtaiBeckley's value of 381.54 is 3750.1% above this benchmark. Historically, AtaiBeckley's own PS Ratio has ranged from 36.59 to 2,450.00 over the past decade. While the company's 10-year median is 740.00 vs. the industry median of 9.91, AtaiBeckley has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PS Ratio for a Biotechnology company?
The median PS Ratio among Biotechnology companies is 9.91, based on 929 companies in the industry. Companies in the top quartile (top 25%) have a PS Ratio significantly above this median, while those in the bottom quartile fall well below. However, PS Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. AtaiBeckley's current PS Ratio of 381.54 is 3750.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PS Ratio mean?
A high PS Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Sales ratio is the ratio of share price to a company's revenue per share. View historical data on AtaiBeckley and its competitors. For the Biotechnology industry, the median PS Ratio is 9.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. AtaiBeckley's current PS Ratio is 381.54, which is 48% below median its own 10-year median of 740.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AtaiBeckley stock overvalued right now?
Based on GuruFocus' analysis, AtaiBeckley (ATAI) is currently considered Possible Value Trap. The stock's GF Value™ is $7.16, compared to a current price of $4.96 — trading 30.7% below its estimated fair value. The current PS Ratio is 381.54, which is 48% below median its 10-year median of 740.00 and 3750.1% above the Biotechnology industry median of 9.91. AtaiBeckley's overall GF Score™ is 56/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PS Ratio calculated?
PS Ratio is calculated from a company's financial statements. For AtaiBeckley (ATAI), the current PS Ratio is 381.54 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is AtaiBeckley (ATAI) Overvalued in 2026?
Based on GuruFocus' analysis, AtaiBeckley stock appears to be undervalued.
The current stock price of $4.96 is trading 30.7% below its estimated GF Value™ of $7.16.
GuruFocus considers AtaiBeckley to be Possible Value Trap.
Key valuation signals for ATAI:
PS Ratio: 381.54 (48% below median its 10-year median of 740.00)
GF Value™: $7.16 vs. price of $4.96 (30.7% below fair value)
Industry Position: 3750.1% above the Biotechnology median (#861 of 929)
No single metric tells the full story. See the ATAI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
56GF Score
Get the complete analysis for ATAI
PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ATAI has been successfully added to your 
